Qualysec

BLOG

CDSCO Medical Device License Audit: Compliance Checklist for Manufacturers

Pabitra Kumar Sahoo

Pabitra Kumar Sahoo

Published On: March 27, 2026

chandan

Chandan Kumar Sahoo

August 29, 2024

CDSCO-Medical-Device-License-Audit-Compliance-Checklist-for-Manufacturer
Table of Contents

Key Takeaways

  • CDSCO Medical Device License Audit requires aligning physical shop-floor practices with our digital quality management system records to meet the success notion.
  • Various cloud models need different protection strategies. The security responsibility of IaaS, PaaS and SaaS is not equal, and therefore, the appropriate controls are dependent on the business usage of cloud.
  • Effective cloud security is based on layered services, not a single tool. IAM, CSPM, workload protection, data security, and compliance monitoring provide essential capabilities for navigating a CDSCO Medical Device License Audit, and organisations best implement them through a single, unified approach.
  • The appropriate provider should minimise risks and support business growth. A competent cloud security partner will provide the visibility, the ability to respond, the support of compliance and will not introduce additional operational complexity.
  • It is best to not only alert but also act on effective cloud security. What is actually worth it is finding significant risks at early stages, assigning the right priorities, and correcting them before they influence the operations.

Introduction

CDSCO medical device license audit is not just a document review. It is the checkpoint that determines whether the medical device manufacturer is actually operating in conformity with the Medical Devices Rules, 2017, with the audit route also depending on the class of device and licensing authority. In Class A and B devices, the audit or inspection steps of the notified body and the State licensing authority take centre stage, as Class C and D devices pass through Central licensing authority inspection of manufacturing buildings and licensing procedures.

 

This is even better now since the Indian medical device industry is in rapid growth. The government commissioned an industry report that observed the Indian medical devices market would be USD 50 billion by 2025. That is one of the reasons why regulating oversight, location preparation, and documentation discipline have become much more significant to manufacturers.

 

And therefore, when manufacturers are searching for CDSCO medical device license audit requirements, the question is not just, Will CDSCO inspect us? Another question is also, are our facility controls, QMS records, technical files, and manufacturing evidence robust enough to survive a class-specific regulatory review? This guide explains the audit process, what triggers it, which documents auditors typically review, and how manufacturers can prepare using a practical compliance checklist.

What Is A CDSCO Medical Device License Audit

A CDSCO medical devices license audit conducted by the CDSCO determines whether a licensed manufacturing facility complies with the terms and conditions. Its license was issued, and whether the system governing quality, production and documentation works as intended in the real world. It focuses on how people perform things on the ground and not on the fact that the documents needed are present.

Short Answer

The CDSCO medical device license audit is a regulatory audit of the manufacturing venue, quality framework, technical documentation and license terms and conditions to ensure regulatory compliance under the Medical Devices Rules, 2017 of India.

What regulators examine in practical terms

In the audit, CDSCO or the authority concerned examines the ability of the manufacturer to show end-to-end control of the operations:

  • Consistency with approved scope: Do the work products, processes, and activities underway match the approval as part of the licence?
  • Implementation of quality systems: Are organisations actively implementing and maintaining processes like deviations, CAPA, change control, and internal audits?
  • Operational traceability: Can we track materials, batches and finished products properly through both manufacturing and testing phases?
  • Records and activities consistency: Do the production data, testing records, and approvals present the real operations without any gaps or inconsistencies?

Beyond documentation: system-level validation

The audit would ensure that:

  • People not only define but also follow systems.
  • They are preventing errors and quality problems.
  • Records are comprehensive, up to date, and verifiable.

One case in point is that a deviation log is not checked just because it is complete. Auditors check whether:

  • Deviations were correctly identified.
  • Appropriate corrective measures were taken.
  • Such problems were prevented in later batches.

Where it applies in the regulatory lifecycle

A CDSCO audit involves multiple regulatory checkpoints rather than a single point:

  • checking of operations readiness before full-scale production.
  • checking compliance after the activities start.
  • periodic evaluation during the operation process.
  • Re-evaluation in the case of manufacturing or quality systems change.

Depending on the type of change or trigger and type of device, the specific pathway varies based on the classification of the device, licensing authority of the device, and the nature of the change.

Which Manufacturers and Licences Fall Under the CDSCO Audit Scope

The scope of a CDSCO medical device license audit is determined by the degree of risk associated with the device and the type of license under which production is conducted. This has a direct impact on the authority that is to audit and the mode of inspection.

Device Class And Audit Authority

DevicesLicensing AuthorityTypical Audit / Inspection Touchpoint
Class A / BState Licensing Authority (SLA)Notified body audit and SLA-linked review
Class C / DCentral Licensing Authority (CDSCO/CLA)Inspection of manufacturing site by CDSCO/CLA team
  • Class A and B Devices: These are lower-risk devices that state authorities regulate. The notified body conducts security assessments, and the State Licensing Authority performs reviews, focusing on observing how teams apply quality systems and comply with license conditions.
  • Class C and D Devices: These are higher-risk devices that central authorities regulate. CDSCO directly inspects manufacturing facilities and places greater focus on production control, infrastructure, and regulatory compliance.

Manufacturing Licence Vs Loan Licence

Audit coverage is also based on the structure of manufacturing:

Manufacturing Licence (Own Facility)

The audit is concerned with the licensed site, including:

  • infrastructure and equipment.
  • production processes
  • Quality systems and records.

Loan Licence (Third-Party Manufacturing)

The audit evaluates:

  • item outsourcing control.
  • understandability of roles between the licence holder and the manufacturer.
  • production and quality record access.

This ensures that organisations uphold accountability even in cases where they do not carry out manufacturing in-house.

Inclusion Of IVD Manufacturers

CSDCO also comes within the scope of auditing manufacturers of in-vitro diagnostic devices (IVDs). Besides the normal checks, audits can involve:

  • diagnostic performance validation.
  • Reagent control and testing material control.
  • uniformity of labelling and purpose of use

Who Falls Under Audit Scope

A CDSCO audit is imposed on a manufacturer in case it:

  • has a valid manufacturing or loan licence according to MDR 2017.
  • manufactures gadgets under the controlled category.
  • carries out activities in the licensed field of operation.

When Does The CDSCO Medical Device License Audit

The audit of a CDSCO medical device license may occur at various stages of the licensing and compliance life cycle. It does not only pertain to first-time approval. Audits can be performed prior to approval, subsequent to approval, throughout licence validity, or following certain changes in the operation of the device, depending on the classes of the device, licensing body and regulatory trigger.

During the Fresh Manufacturing Licence Review

Review of new manufacturing licence applications is one of the most significant audit points. In this phase, the regulators determine whether the activity requested is being supported by the site, systems and records.

This review may include verification of:

  • facility preparedness towards the intended manufacturing activities.
  • application of quality control and processes.
  • accessibility of subsidiary technical and regulatory documents.
  • conformity between the application submitted and the site conditions

In the case of higher-risk equipment, regulators increase oversight because inspection results can directly determine whether they grant the licence.

During Post-Approval Changes, CDSCO Medical Device License Audit

A CDSCO audit can also be prompted after approval by significant changes that influence the initial basis of licensing.

These may include:

  • Introduction of new products within the licensed field.
  • modifications in production procedures.
  • modifications to equipment or infrastructure that have an impact on production control.
  • changes that modify quality system implementation or management.

Regulators, in this case, might check whether the approved location continues to comply with the conditions under which they initially granted the licence.

During Retention And Continued Compliance Review

According to the Medical Devices Rules, 2017, compliance by the manufacturers is anticipated during the age of the licence. This implies that audit or inspection activity can occur within the period of the licence to ensure that systems do not become obsolete.

These reviews usually revolve around the fact that the manufacturer has maintained:

  • Good quality system implementation.
  • revised technical and production specifications.
  • management of changes, deviations, and complaints.
  • conformity to licensed scope and approved operations.

This is why organisations need to view audit readiness as a continuous process rather than a one-time preparation.

On Risk Signals, Complaints, Or Regulatory Concerns


CDSCO can carry out audits in a risk-based manner when indications arise that may cause regulatory concern. Those are not regular audits, but specific interventions aimed at checking whether the controls used by the manufacturer are still valid.

Possible triggers include:

  • complaints of product, quality or safety issues.
  • negative incidents associated with the device.
  • field corrective actions or recalls.
  • disagreements found in the process of regulations.
  • surveillance intelligence or compliance intelligence.

Under such circumstances, audits can be more intensive in the area of concern than the entire site.

After Major Site Or Operational Changes for CDSCO Medical Device License Audit

Some of these changes are too important to warrant a re-assessment of the licensed manufacturing arrangement. A significant one of them is the change of location of manufacturing sites, which would need re-inspection or re-audit of the QMS before regulators consider the new arrangement.

Other examples may include:

  • change of location of the licensed facility.
  • significant growth in the places of production.
  • significant alteration in managed production settings.
  • system or process changes that influence the physical location management of quality.

Such cases are noteworthy because the initial approval is conditional on the site and process.

Partner with Qualysec for a Comprehensive Compliance Audit to identify hidden risks and ensure your most intensive regulatory security.

 

Find Your Perfect Security Partner

How Audit Timing Works In Practice

Practically, CDSCO audits are not calendar-based but are instead trigger-based and lifecycle-based.

Audit TriggerWhen It HappensWhat Is Reviewed
Fresh Licence ReviewBefore approvalFacility readiness, QMS, technical records
Post-Approval ChangesAfter modificationsProcess changes, new products, infrastructure updates
Ongoing Compliance ReviewDuring licence validityQMS performance, records, deviations
Risk-Based AuditOn complaints or issuesSpecific risk areas, product quality concerns
Major Site ChangesAfter relocation or expansionDuring the licence validity

CDSCO Medical Device License Audit Requirements For Manufacturers

CDSCO Medical Device License Audit Requirements For Manufacturers

CDSCO audit requirements for medical device manufacturers require them to demonstrate that all licensed activities utilise systems that control, document, and consistently implement those activities. These requirements are compatible with the Medical Devices Rules, 2017, and concern whether manufacturers can demonstrate compliance in operational aspects, including quality, production, and regulatory controls.

This area is among the most important aspects of a CDSCO medical device license inspection audit since it dictates how well the manufacturer’s systems ensure the quality of products and meet regulatory standards in the long term.

1. Quality Management System And Site Compliance

One of the expectations during CDSCO audits is the existence of a working Quality Management System (QMS). Regulators determine the presence of the system that manages manufacturing activities rather than merely keeping it in the form of documents.

The main aspects that are normally considered are:

  • Manufacturing, quality and support processes Standard Operating Procedures (SOPs).
  • CAPA and deviation management systems, which identify, rectify and avoid.
  • Change control processes to deal with changes in processes, products or systems.
  • Audit programs internally to check on continuing compliance.
  • Personnel, manufacturing and quality training and competency records.

In addition to QMS, site compliance is also verified:

  • Process flow corresponded with the facility layout.
  • isolation of restricted space where necessary.
  • Equipment qualification and condition of maintenance
  • production aids in terms of environmental and utility controls.

The emphasis focuses on whether the site and QMS are controlled systems that work together with each other.

2. Technical Documentation And Device Files

Manufacturers have to maintain all licensed devices with complete and up-to-date technical documentation. Such records facilitate regulatory safety and should be consistent with the real manufacturing and product specifications.

Auditors may review:

  • specifications and application of devices.
  • manufacturing and design specifications.
  • documentation and validation data that are related to risks.
  • labelling, instructions of use (IFU), and version control.
  • traceability of components and materials.

The expectation is that technical records are:

  • conform to the licensed product.
  • version managed and controlled.
  • documented by implementation evidence.

3. Production, Testing, And Release Controls

CDSCO audits are very keen on the manufacture, security testing, and release of products. This segment ensures that there is control of production processes and that production outputs are of specified specifications.

Key elements include:

  • documentation of each production cycle, batches or lot manufacturing.
  • In-process quality checks to check the consistency of the products.
  • Last testing and inspection precedes release.
  • product release approval with responsibility to approve.
  • correction of non-conforming products and correctional measures.

Auditors evaluate whether:

  • actual manufacturing activity is equated with production records.
  • Testing is done as they become necessary.
  • Only compliant goods are issued.

4. Conditions And Record Retention

Manufacturers are not allowed to go outside their conditions as stipulated in their licence. CDSCO audit checks whether all the activities are in accordance with the approved scope.

This includes:

  • producing only certified types of devices.
  • working under the licensed facility and infrastructure.
  • caring compliance with the relevant regulatory duties.

Record retention is equally important:

  • records of production, tests and quality, which should be stored and accessible.
  • Records must be comprehensive, well-organised, and auditable.
  • Records are required to uphold product lifecycle traceability.

With MDR 2017, there are no one-time approval or periodic renewal requirements because of the continuous compliance and retention requirements.

5. What This Means for Manufacturers

The accomplishment of CDSCO audit requirements does not involve a matter of preparing documents and inspection just before. It requires maintaining:

  • uniformity in the execution of procedures.
  • proper and full records.
  • congruence in licensed and real operations.

Ensured that at any given time, the manufacturer will be able to articulate complete control over quality, production, and compliance with the rules and regulations, which is the essence of the CDSCO audit.

Documents Required During A Manufacturing CDSCO Medical Device License Audit

In a CDSCO medical device license audit, auditors do not examine records alone. Records help them determine whether teams perform manufacturing, quality, and regulatory controls properly and consistently. This renders document preparedness a significant aspect of audit preparedness.

It is expected that the records are:

  • complete and up-to-date
  • consistency with real-life operations.
  • easy to access when under inspection.

A list of the most important documents that will be considered when a CDSCO manufacturing license audit is conducted is given below

Key Documents And What Auditors Verify

Document CategoryWhat Auditor Will Usually Look For
Manufacturing Licence / Loan LicenceValidity, device class, approved scope, licensed site details
Site Master FileFacility layout, manufacturing flow, utilities, controlled environments
QMS DocumentsSOPs, deviations, CAPA records, change control, internal audit reports
Device Technical RecordsSpecifications, intended use, design and manufacturing details
Validation And Qualification RecordsProcess validation, equipment qualification, cleaning, sterilization, software validation
Raw Material And Supplier RecordsApproved versions, control over labelling, instructions for use
Batch / Lot Manufacturing RecordsTraceability, production steps, reconciliation, approvals
QC / Testing RecordsIn-process checks, final testing results, acceptance criteria
Complaint And Vigilance FilesComplaint handling, adverse events, recalls, field actions
Training And Personnel RecordsEmployee competency, role-based training, authorization records
Calibration And Maintenance LogsEquipment calibration status, preventive maintenance records
Labeling / IFU / Pack RecordsApproved versions, control over labeling, instructions for use

How These Documents Are Evaluated

The auditors normally evaluate documentation from three perspectives:

  • Accuracy: The presence or absence of records which show actual manufacturing and quality activities.
  • Completeness: Is there a record of all needed steps, approvals and controls
  • Traceability: It is possible to trace materials, processes and finished products on an end-to-end basis

As an example, batch records are not only validated when it comes to the entries, but also:

  • alignment with timelines of production.
  • connection of raw materials and test outcomes.
  • proper review and approval

Common Documentation Gaps Observed

Manufacturers are usually subjected to audit observation because of:

  • uncovered or non-uniform batch records.
  • obsolete SOPs or unmanaged versions of documents
  • Absence of validation or qualification evidence,
  • lapses in CAPA records, or follow-up.
  • inability to trace throughout production and testing.

Why Documentation Matters In CDSCO Audits

Control is demonstrated by documentation. It enables regulators to establish that:

  • procedures are adhered to in a prescribed way.
  • Quality systems are operating well.
  • Manufacture of products is under controlled conditions.

Even the best laid down processes can fail the audit test without the presence of good documentation.

That is why documentation is not a mere collection preparation. It is concerning the promotion of the fact that all records contribute to the general compliance story of the manufacturing system.

Get a Detailed Sample Penetration Testing Report with CDSCO medical device license audit!

 

Get a Free Sample Pentest Report
Penetration Testing Report

CDSCO Compliance Checklist For Manufacturers Before The Audit

One should not simply compile the documents to prepare a CDSCO medical device license audit. Manufacturers must ensure their facilities are in good shape and ready for audits within their quality systems, records, and processes at any time.

This is a checklist that has been created as a practical pre-audit readiness model to assist manufacturers in ensuring CDSCO compliance before inspection.

Facility And Infrastructure Readiness

  • Ensure that the place of manufacture is the same as the licensed address and layout.
  • Ensure that there is a clear definition of production areas, storage and controlled areas that are well maintained.
  • Make sure that the equipment is qualified, calibrated and that its maintenance schedules.
  • Checking the availability and management of utilities like HVAC, water systems, and power backup.
  • Verify that material and personnel movement contribute to the control of contamination and integrity of the process.

QMS And SOP Readiness

  • Make sure that all SOPs are up-to-date, approved and versioned.
  • Confirm that CAPA records are complete, closed and evidenced.
  • Proper investigation and correction of deviation logs.
  • Confirm that change control records indicate all the new changes in the processes or systems.
  • Ensure that internal audits have been made, and results have been dealt with.

Technical File And Licensing Readiness

  • Ensure that the specifications and the intended use of the device are in line with the licensed scope.
  • Make sure that the technical documentation is in place and is consistent with modern production.
  • Certify that the labelling, IFU and packaging records have been controlled and updated.
  • Check that the products that are approved are not out of the licence.
  • Check regulatory compliance submissions and on-site documentation.

Batch Record And Traceability Readiness

  • Check the completeness and accuracy of the manufacturing records of batches or lots.
  • Record each production procedure, tests and confirmations.
  • Confirm traceability of the raw materials to the finished products.
  • Ensure that the materials and outputs reconciliation is correct.
  • Ensure that product release decisions are well-authorised and documented.

CAPA, Complaints, And Change Control Readiness

  • Make sure to record and probe all complaints and adverse events.
  • Ensure that CAPA practices are in place and working.
  • Check that someone records and closes recalls or field actions, where applicable.
  • The team considers and approves change controls before implementation.
  • Confirm that there are systematic solutions to recurrent problems.

Mock Audit And Evidence Folder Readiness

  • Carry out an internal simulated mock audit of CDSCO inspection conditions.
  • You should create a centralised evidence folder containing important documents.
  • Determine audit coordination and document presentation roles.
  • Make the staff trained on how to respond correctly in the interview.
  • Confirm that there are no delays in retrieving any records.

What This Checklist Helps Achieve

This checklist will make sure that manufacturers can:

  • show actual compliance in case of inspection.
  • minimise the risk of audit observation or delay.
  • provide a disciplined and organised manufacturing set-up.

A CDSCO audit does not test preparation done just before the inspection. It evaluates whether systems are consistently maintained and audit-ready at all times.

How To Prepare For A CDSCO Medical Device License Audit in India

This aims to ensure that systems, records, and operations align with the regulatory expectations of MDR 2017 at each level. The following are the steps that manufacturing companies can use to prepare.

Confirm Licence Scope And Approved Site Details

First, ensure that all operations are in line with the accepted terms of the licence:

  • authenticate licensed device categories and classifications.
  • Check the manufacturing location address and plan.
  • Monitor that all the carried-on activities are within the authorised scope.

Audit observations can be a result of any discrepancy between actual operations and licensed information.

Map Applicable MDR 2017 And Class-Based Requirements

Determine the specific regulatory conditions that are applicable under:

  • classification of device (A, B, C or D)
  • kind of licence (manufacturing or loan licence)
  • Relevant quality and compliance requirements.

This would facilitate consistency in ensuring that the preparation of the audit is not generic to the regulatory expectations.

Review Previous Audit Observations And CAPA Status

In case previous audits or inspections have been done:

  • Check on all observations and findings.
  • Ensure that corrective measures are taken and closed.
  • Make sure that preventive precautions are taken to prevent recurrence.

The unresolved or recurring problems are usually raised during future audits.

Organise Master Documents And Controlled Copies

Plan a system of access to documents:

  • Keep management copies of SOPs and quality documents.
  • systematise technical files, batch files and validation data.
  • have documents indexed and readily accessible.

Auditors want to have fast access to records without delays and inconsistencies.

Conduct an Internal Audit Or Mock Walkthrough

Test preparation by simulating a CDSCO audit environment:

  • carry out a complete internal audit with respect to the facility, QMS and records.
  • Visit production zones and checkpoints of quality control.
  • determine documentation, execution or traceability gaps.

This is done to identify problems at the pre-audit stage.

Verify Data Integrity, Traceability, And Release Records

Make sure that all data in operation is reliable:

  • ensure that batch records are complete and valid.
  • Trace the movement of raw materials to the finished product.
  • consistency in review testing and approvals of releases.

One of the most frequent audit issues is the inconsistency of data.

Train Front-Room And Back-Room Audit Teams

Define the roles of the handling of audits:

  • Assign front-room staff to deal with auditors.
  • devise back-room assistance in document retrieval and coordination.
  • train employees to deliver correct, consistent and controlled responses.

Free-flowing communication may be confusing in audits.

Prepare Escalation Path For Major Observations

Determine the response of the organisation in case of problems:

  • Assign decision-making responsibility to the personnel in the audit.
  • put into place a mechanism of clarification or documentation support on the spot.
  • guarantee the ability to respond swiftly to critical observations.

This assists in keeping control in unforeseen audit circumstances.

What This Preparation Approach Ensures

Such an organised process assists manufacturers:

  • show domination of operations and documentation.
  • minimise the possibility of significant audit discoveries.
  • Answer questions with authority in the process of inspection.

One CDSCO audit is not demonstrating compliance one time. It demonstrates how systems are always maintained, monitored, and in line with the requirements of regulations at all times.

What Happens During The Audit

What Happens During The Audit

CDSCO medical device license audit has a systematic inspection flow. Although the depth may vary depending on the type of device and the audit trigger, the general workflow assesses facility operations, quality systems, documentation, and personnel knowledge in a structured and regulated manner.

It is the knowledge of this flow that can assist manufacturers in preparing at an operational and team level.

1. Opening Meeting

The auditors and the team at the manufacturer will normally initiate the audit with a prelude.

This stage includes:

  • presentation of the audit team and representatives of the company.
  • certification of the scope of audit, audit objectives and areas to be covered.
  • Overview of manufacturing and product groups.
  • elaboration of logistics, including document access and movement on the site.

This gives a vision and alters the direction of the inspection prior to the start of the inspection.

2. Site Walkthrough

Auditors then proceed to the manufacturing plant to see what is really going on.

They can also check during the walkthrough:

  • process flow and production areas.
  • practices in material storage and handling.
  • condition of equipment, calibration and use.
  • environmental controls and utilities.
  • separation of restricted and unrestricted zones.

The aim is to ensure that physical operations are in line with documented processes.

3. Document Review

Auditors review significant books after or together with the walkthrough so as to check compliance.

This typically includes:

  • Quality system documentation and SOPs.
  • test and manufacturing records of batches.
  • validation and qualification information.
  • CAPA, deviation and change control records.
  • technical files and licensing documents.

Auditors are cross-checking whether:

  • Records are thorough and correct.
  • Record keeping is consistent with activities.
  • approvals and controls are appropriately put in place.

4. Interviews With Key Personnel

Auditors can deal with staff in manufacturing and quality operations.

The following are evaluated using these discussions:

  • knowledge of SOPs and roles.
  • Understanding of quality processes and management.
  • The capability to describe processes and actions undertaken in deviations.

The reviewers critically assess the coherence among the answers given by the personnel, the written guidelines, and the real activities.

5. Observation Discussion And Closeout Meeting

At the close of the audit, the auditor conducts a discussion with the manufacturer’s team.

This includes:

  • presentation of observations or deficiencies identified.
  • Explanation of areas which need to be corrected.
  • response and compliance discussion.

The severity of observations can vary, and usually, we expect the manufacturers to give a CAPA response within a specific period.

6. What This Means For Manufacturers

The audit does not embrace a single area. It connects:

  • facility conditions
  • process execution
  • documentation accuracy
  • personnel understanding

This combined assessment ensures that all levels of operations comply, rather than confining themselves to single systems.

The preparedness for every phase of the audit is useful in assisting manufacturers to keep control, react and lower the possibility of critical observations.

Common Findings In CDSCO Medical Device License Audit Manufacturing

In case of a CDSCO medical device license audit, auditors normally increase observations where there is a disparity between the written procedures and the actual execution. Such findings do not necessarily stem from no systems, but rather due to inconsistency, incompleteness of records or poor control over processes.

Finding AreaTypical IssueRisk Impact
DocumentationMissing or inconsistent recordsCompliance gaps
CAPAIncomplete or ineffective closureRepeated issues
TraceabilityWeak batch linkageProduct recall risk
CalibrationExpired or missing recordsData reliability issues
ValidationIncomplete validationProcess inconsistency
Change ControlUncontrolled changesCompliance breakdown
TrainingUntrained personnelOperational errors
LabelingVersion mismatchRegulatory non-compliance

Knowledge of these similar spaces assists manufacturers in carrying out internal inspection prior to the inspection process.

Documentation Gaps

Another finding that is very common is that of incomplete or inconsistent documentation.

Typical issues include:

  • lost records in the batch or testing records.
  • obsolete or unmanaged versions of SOPs
  • Partial approval or review signatures.
  • mismarks among various records.

Insufficient documentation can cause compliance issues, even with follow the processes.

Incomplete CAPA Closure

The audits involve close scrutiny of CAPA systems. Typical observations are:

  • Effective measures were not entirely put into effect.
  • insufficient evidence on the effectiveness of CAPA.
  • an unprevented recurrent problem.
  • delays in CAPA closure

Auditors expect CAPA to show root cause, action implementation, and effectiveness verification.

Poor Traceability Or Batch Record Issues

Medical device manufacturing depends heavily on traceability. Findings may arise when:

  • Finished products cannot be associated with raw materials.
  • Records at batch levels are partial or incoherent.
  • Materials reconciliation is not clear.
  • There is no appropriate connection between production and testing data.

These gaps may impact the possibility of tracking the quality of products and exploring problems.

Equipment Calibration And Maintenance Lapses

Manufacturing and testing equipment should also be regulated, and their maintenance taken care of.

Common issues include:

  • expired calibration status,
  • lost records of maintenance.
  • Inequality of equipment qualification documentation.
  • operating equipment without due validation.

These gaps bring doubts about the accuracy of production and testing results.

Validation Gaps

Validation is the process that makes sure that processes always give the desired results. Findings may include:

  • Lacking or insufficient validation studies.
  • absence of revalidation due to process changes.
  • lack of adequate records of validation outcomes.
  • lack of clarity about the criteria of acceptance.

Auditors evaluate the validity and evidence-based critical processes.

Weak Change Control Practices

Change control is important to ensure the integrity of the systems.

Typical observations are:

  • process or equipment alterations not documented.
  • deficiency in impact evaluation prior to effecting change.
  • modifications which are not sanctioned by the formal procedures.
  • disagreements between revised procedures and records.

This may result in uncontrolled fluctuations in production.

Training And Personnel Gaps

During audits, personnel competency is also tested.

Issues may include:

  • lost or obsolete training documentation.
  • employees that do not understand the latest SOPs.
  • lack of role-based training
  • Inadequate records of competency analysis.

The auditors require the personnel to show the knowledge, together with the training reported.

Labeling And Version Control Issues

Control of labelling and documentation is essential in regulatory compliance.

Common findings include:

  • use of ineffective labels or IFUs.
  • absence of document versioning.
  • disagreement between accepted and utilised labelling
  • The lack of approval documentation on the revised documentation.

Such problems may impact product recognition and compliance.

How To Use These Findings

These are not the audit risks only. They are self-examination points that the manufacturers of the self-check points can use to determine readiness prior to the inspection.

  • By covering these areas at an early stage, organisations can:
  • Reduce audit observations
  • improve system reliability
  • Enhance general compliance positioning.

The majority of auditing results of CDSCO can be inhibited if reliable documentation is regularly carried out, observed, and provided by the systems.

What Happens If A Device Or Site Fails A CDSCO Medical Device License Audit

When a CDSCO medical device license audit reveals some serious gaps, the results will depend on the character, the seriousness and the consequences of the audit. The failure of an audit is not necessarily the end of the licence, though it initiates regulatory measures, rectification, and suspension of activity.

1. Observations And Deficiencies Raised

CDSCO, or the authority at the end of the audit, makes observations depending on some gaps being identified.

These may include:

  • minor gaps to be filled, which do not affect the compliance in general.
  • significant gaps that manifest a weakness in quality systems or process control.
  • critical gaps that can cause product safety, data integrity, or regulatory compliance violations.

These findings are classified, and the course of action depends on this classification.

2. Requirement For CAPA Response

The manufacturers are usually expected to provide a Corrective And Preventive Action (CAPM) response within a specified period of time.

Such a response must involve:

  • root cause analysis of all observations.
  • rectification measures to counter the problem.
  • prophylactic steps to prevent the occurrence.

corroborating materials like revised records or validation information.

The partial or insubordinate CAPA actions may result in additional regulatory climb.

3. Follow-Up Verification Or Re-Inspection

Based on the severity of findings, CDSCO might:

  • CAPA documentation was accessed remotely.
  • Carry out a follow-up inspection to confirm implementation.
  • Demand further evidence or explanation.

Unresolved or critical issues usually entail re-inspection on the ground before they are considered to be in compliance.

4. Impact On Licensing Status

The success of the medical device audit may have a direct impact on the licence of the manufacturer.

  • temporary approval, pending closure by CAPA.
  • postponement in granting or renewal of licences.
  • limitation of production or sale processes.
  • suspension or cancellation of the licence in extreme cases.

The determination is based on whether the gaps affect the quality of products, safety, or regulations.

5. Business And Operational Impact

Outside the regulatory ramifications, audit failure may impact:

  • availability of the products in the market.
  • trust and reputation of customers.
  • new product approval schedules.
  • remediation allocation of internal resources.

This renders audit outcomes to be a regulatory and business issue.

6. How Manufacturers Should Respond

In case a CDSCO audit has serious findings, then it should concentrate on:

  • being able to prioritise important issues at the moment.
  • making sure that CAPA activities are realistic and evidence-based.
  • verifying fixes either internally or by retesting
  • Enhancing systems to avert recurrence.

A failed CDSCO audit does not concern individual issue correction. It involves showing that there is an improvement in the strength of the underlying systems, and they can ensure compliance at all times.

How Qualysec Supports Compliance For CDSCO Medical Device License Audit Manufacturers

How Qualysec Supports Compliance For CDSCO Medical Device License Audit Manufacturers
How Qualysec Supports Compliance For CDSCO Medical Device License Audit Manufacturers

Many times, manufacturers have to make several systems, records, and processes that meet the regulatory expectations to prepare in case of an audit of a CDSCO medical device license. Qualysec assists in this process since it assists organisations in recognising gaps, organising compliance and enhancing audit readiness without interfering with the normal operation of the organisation.

1. Audit-Readiness Review

Qualysec undertakes systematic tests to determine whether the site of manufacture, documentation and quality systems are in line with CDSCO requirements.

This includes:

  • assessment of setting up facilities and process flow.
  • Comparing the application of QMS in operations.
  • recognising discrepancies between the scope of the license and the real operation.

2. QMS And Documentation Gap Assessment

One of the main components of audit preparation is that documentation should represent real operations.

Qualysec helps manufacturers:

  • Review SOPs, CAPA records and control systems change.
  • Evaluate completeness and consistency of quality documentation,
  • Find defects in traceability, validation and record management.

3. Mock Regulatory Audit

Simulated audits are conducted by Qualysec to simulate the conditions of CDSCO inspection.

This helps organisations:

  • Test preparedness in the facility, documentation and personnel.
  • Detect possible audit observations.
  • Enhance the coordination of response in case of real audits.

4. CAPA Support And Remediation Guidance

Qualysec aids in building viable CAPA plans when gaps are found among the manufacturers.

This includes:

  • root cause analysis of the identified issues.
  • specifying remedial and preventive measures.
  • making sure that the actions are in line with system-level improvements.

5. Technical File And Evidence Organisation

The success of an audit is determined by the ways in which compliance can be evidently illustrated.

Qualysec assists in:

  • structuring of technical and regulatory documentation.
  • organising data to be easily accessed during auditing.
  • Getting records in line with the CDSCO requirements

6. What This Support Enables

Through systematic support, manufacturers will be able to:

  • improve audit preparedness,
  • minimise the risk of important observations.
  • exhibit regular operations, control and compliance.

Qualysec’s strategy is based on assisting manufacturers to construct pragmatic, audit-prepared systems capable of enduring the regulatory review as per CDSCO necessities.

Final Compliance Checklist Before Your CDSCO Medical Device License Audit

This brief checklist will help to verify that you are ready in the main aspects before a CDSCO medical device license audit:

  • Licence Scope Verified: All the manufacturing related activity and products are in accordance with the licence and approved device classification.
  • Approved Products Matched To Records: Licensed devices are in line with technical files, labels, and production records.
  • QMS Records Updated: SOPs, CAPA, deviations and change controls are up-to-date and duly authorised.
  • Validations Current: Software, equipment, sterilisation, and cleaning and process validation are complete and up to date.
  • CAPAs Closed or Justified: Teams implement, record, and monitor the effectiveness of all corrective measures.
  • Complaints and Vigilance Files Current: Teams record and resolve adverse events, complaint handling, and any field actions.
  • Training Records Current: Teams record personnel training, align it with job roles, and keep it consistent with existing SOPs.
  • Audit Team Briefed: It has front-room and back-room roles, and documents are easily available.

Conclusion

A CDSCO medical device license audit is not a one-time regulation that occurs once. It is a continuous monitoring of whether the manufacturing systems, quality processes and documentation are compliant with the Medical Devices Rules, 2017. Since various levels, such as licensing and post-approval changes, as well as risk-based events, may initiate audits, manufacturers need to be ready to be constantly compliant.

 

The presence of systems is not the only important thing, but being capable of proving that there was control, consistency, and traceability of operations at any given time. Manufacturers that consider audits as an aspect of daily operation discipline are in a better place to evade observations and even sustain licensing in continuity.

 

In the case of structured support in companies that require it, Qualysec assists manufacturers in enhancing audit preparedness by providing a gap assessment, mock audit, documentation verification, and CAPA support, in accordance with the requirements of CDSCO. This is to make sure that compliance is not a reaction, but is designed into the system itself.

 

Even when your organisation is about to undergo a CDSCO audit or simply wants to confirm your current level of compliance, reach out to Qualysec to find out how a well-organised and audit-ready program can help your regulatory and operational objectives.

 

Are you willing to secure your medical device? Contact Qualysec Technologies today to get the professional services of a CDSCO cybersecurity audit!

Speak directly with Qualysec’s certified professionals to identify vulnerabilities before attackers do.

FAQs

Q. What is a CDSCO medical device license audit?

CDSCO medical device license audit is a regulatory inspection that reviews the compliance of a manufacturing facility, quality management, technical documentation, and licensing terms of the facility with the Medical Devices Rules, 2017 in India. It dwells on the real operational control verification as opposed to documentation.

Q. When does CDSCO conduct license audits?

CDSCO performs audits when it reviews the initial licence, approves the licence, reviews the licence validity, identifies a major change, or responds to risk signals of complaints or quality issues. Its schedule is dependent on phases of the life cycle and regulatory cues as opposed to a regular one.

Q.What documents are required during a CDSCO medical device license audit?

Some of the documents auditors usually check are manufacturing licences, site master files, QMS documents, technical records, validation data, batch records, testing records, complaint files, training files and calibration logs. Such documents should be full, precise and in harmony with real operations.

Q. How can manufacturers prepare for a CDSCO compliance audit?

Preparation tasks that manufacturers can undertake include checking the scope of the licence, updating the QMS records, tracing, internal audit, documentation organisation and training staff. Process-based strategy, in an organised way, will aid in minimising audit risks.

Q. What happens if a device fails a CDSCO audit?

In case of any major shortcomings detected, regulators might force the manufacturers to file CAPA responses, to be re-inspected, or to face regulatory measures such as delays, restrictions, or even loss of licence, based upon the seriousness of the results.

Qualysec Pentest is built by the team of experts that helped secure Mircosoft, Adobe, Facebook, and Buffer

Pabitra Kumar Sahoo

Pabitra Kumar Sahoo

CEO and Founder

Pabitra Sahoo is a cybersecurity expert and researcher, specializing in penetration testing. He is also an excellent content creator and has published many informative content based on cybersecurity. His content has been appreciated and shared on various platforms including social media and news forums. He is also an influencer and motivator for following the latest cybersecurity practices. Currently, Pabitra is focused on enhancing and educating the security of IoT and AI/ML products and services.

Leave a Reply

Your email address will not be published.

Save my name, email, and website in this browser for the next time I comment.

0 Comments

No comments yet.

Chandan Kumar Sahoo

CEO and Founder

Chandan is the driving force behind Qualysec, bringing over 8 years of hands-on experience in the cybersecurity field to the table. As the founder and CEO of Qualysec, Chandan has steered our company to become a leader in penetration testing. His keen eye for quality and his innovative approach have set us apart in a competitive industry. Chandan's vision goes beyond just running a successful business - he's on a mission to put Qualysec, and India, on the global cybersecurity map.

3 Comments

emurmur

John Smith

Posted on 31st May 2024

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut et massa mi. Aliquam in hendrerit urna. Pellentesque sit amet sapien fringilla, mattis ligula consectetur, ultrices mauris. Maecenas vitae mattis tellus. Nullam quis imperdiet augue.

    Pentesting Buying Guide, Perfect pentesting guide

    Subscribe to Newsletter

    Scroll to Top
    Pabitra Kumar Sahoo

    Pabitra Kumar Sahoo

    COO & Cybersecurity Expert

    “By filling out this form, you can take the first step towards securing your business, During the call, we will discuss your specific security needs and whether our services are a good fit for your business”

    Get a quote

    For Free Consultation

    Pabitra Kumar Sahoo

    Pabitra Kumar Sahoo

    COO & Cybersecurity Expert